Posted by Michael Wonder on 17 Nov 2022
Amarin announces Vazkepa (icosapent ethyl) approved by the TGA in Australia
15 November 2022 - Marks fifth regulatory approval for Vascepa/Vazkepa franchise in key international markets in 2022.
Amarin Corporation today announced that Australia’s TGA has granted approval to Vazkepa (icosapent ethyl).
